Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.24 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1662
    +0.0010 (+0.08%)
     
  • GBP/USD

    1.2569
    +0.0022 (+0.18%)
     
  • Bitcoin GBP

    50,125.62
    -1,036.11 (-2.03%)
     
  • CMC Crypto 200

    1,365.16
    +52.53 (+4.00%)
     
  • S&P 500

    5,162.33
    +34.54 (+0.67%)
     
  • DOW

    38,794.04
    +118.36 (+0.31%)
     
  • CRUDE OIL

    78.22
    +0.11 (+0.14%)
     
  • GOLD FUTURES

    2,332.20
    +23.60 (+1.02%)
     
  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     
  • HANG SENG

    18,578.30
    +102.38 (+0.55%)
     
  • DAX

    18,175.21
    +173.61 (+0.96%)
     
  • CAC 40

    7,996.64
    +39.07 (+0.49%)
     

Hofseth Biocare ASA :Mandatory notification of trade, primary insider in HBC

Angelika Florvaag, Quality manager in Hofseth BioCare ASA, has today 30.12.2016 purchased 10,000 shares at an average price of 1.20 per share in Hofseth BioCare ASA. After this, Angelika Florvaag holds 10,000 shares in Hofseth BioCare ASA, corresponding to 0.004% of the shares in Hofseth BioCare ASA. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hofseth Biocare ASA via GlobeNewswire

HUG#2068244